Emmanuel Caeymaex

Biography

Mr. Caeymaex joined Dermira as a director in January 2017. He is currently at UCB serving as Executive Vice President, Immunology Patient Value Unit Head, where he leads the worldwide development and commercialization of innovative patient-oriented solutions for people suffering from various auto-immune disorders and skin conditions. Prior to his current role, Mr. Caeymaex served in various positions at UCB or its affiliated companies, including as Vice President, Senior Global Project Leader of the CIMZIA® Global Patient Solutions team at UCB Biopharma SPRL from June 2011 to February 2015 and as President of UCB Japan Co Ltd. from September 2006 to June 2011.

Research Interest

 Skin Conditions, Dermatology